Professional Documents
Culture Documents
Breast Cancer
Mixed Results
Long-time association of increased estrogen levels and breast CA WHI arm of est/pro showed relative risk of 1.24 (over 5 years) ~1 case/1000ptyears Est alone RR of .77 (? significance)
Endometrial Cancer
Known increase in risk with unopposed estrogen WHI showed no signif risk of CA with combined tx
Increased risk of bx for irregular bleeding
Ovarian Cancer
No overt correlation b/w combined HRT and ovarian CA risk
42 vs 27 cases per 100,000 pt/years (RR 1.6, but small numbers)
Colorectal Cancer
Signif Risk Reduction of Colon CA with combined Est/Pro
43 vs 72 cases
While less cases, trend toward worse prognosis (nodal spread) No risk reduction observed with estrogen alone
Osteoporosis
Well established Risk reduced at hip, vertebrae, and wrist over placebo Similar numbers for estrogen alone vs combined tx.
Dementia
Presumed correlation with longterm estrogen and cognitive fxn WHIMS (memory study)
NO benefit Insignificant increase in incidence No evid for short or long term use in prevention of Alzheimers
Vasomotor Symptoms
Signif Reduction in hot flashes Mod improvement in sleep Well-known and unchanged (WHI predominantly asymptomatic, older women, not target of study)
Urogenital Symptoms
Can preclude occurrence of atrophic vaginitis Thought to prevent urinary incontinence, contradicted by WHI and HERS
Cardiovascular Disease
Counter to previous belief, very small increase in risk of CV events with combined tx (6-7 cases per 10,000 person/years, increase in nonfatal MI)
Corroboration of HERS-I, HERS-II, WAVE
Estrogen alone did not show increase in risk of CV events, ? protective effect for younger women
CV Disease, contd
Stroke
Confusing results based on where you look for data Meta-analysis of randomized trials to include WHI, HERS, WEST suggest increase in ischemic, but not hemorrhagic stroke Stroke more likely fatal in patients taking oral estrogen
CV Disease, contd
Venous Thromboembolism
Small numbers, but roughly 2-fold increase in incidence with oral combined therapy (3.5 vs 1.7 events per 1000 patient/years) Less significant risk increase with estrogen alone (still present, HR 1.3)
2003, q. 106 A 60 year-old female has been on conjugated equine estrogens/medroxyprogesterone (prempro) since she went through menopause at age 52. She still has her uterus and ovaries. She is having no side effects that she is aware of and is experiencing no vaginal bleeding. She is worried about the health effects of her hormone replacement therapy and asks your advice about risks versus benefits.
Which one of the following would be accurate advice regarding these risks and benefits? The The The The The incidence of stroke is decreased incidence of myocardial infarction is decreased incidence of pulmonary embolism is decreased risk of breast cancer is increased incidence of colorectal cancer is increased
Overview
Current indications (brief? Tx)
Vasomotor sxs Sleep disturbance Urogenital changes
Osteoporosis prevention
Increase in ischemic stroke Increase in DVT, PE Mild increase in breast CA risk for combined tx Increase in inconclusive mammograms Increase in GB dz with combined tx
Additional Options
Osteoporosis
Vasomotor Symptoms
Pharmacologic Therapies
SNRIsVenlafaxine (Effexor) shows good results SSRIsParoxetine with good data, fluoxetine less but helpful Megestrol Acetate (synthetic progestin) hot flash reduction of 85% vs 21% for placebo (wt gain side effect)
Vasomotor Symptoms
Pharmacologic Therapies
Clonidine--alpha-2 adrenergic agonist
Herbal Options
These wonderful adaptogenic and balancing plants are truly the wealth of the rainforest. Women rely on in their time of need. *the ingredients may be subject to change
Vasomotor Symptoms
Herbal/Complementary Compounds
Black CohoshEuropean studies support use, mixed (mostly positive results in small trials) Soy Compoundsflaxseed, red clover long term studies and meta-analyses show no benefit
Vasomotor Symptoms
Not Helpful
ginseng, dong quai, evening primrose oil, acupuncture, wild yam, progesterone creams, vitamin E
2003, q. 131
In the postmenopausal woman with hot flashes who cannot take estrogen, which one of the following may help? Diazepam (Valium) B-Blockers Clonidine (Catapres) Meclizine (Antivert) Vitamin C
2003, q. 14
Black Cohosh (Cimicifuga racemosa) is an herbal remedy used by patients for dementia menopausal symptoms nausea and vomiting benign prostatic hypertrophy osteoarthritis
Urogenital Symptoms
Estring
low dose, local effect No effect on vasomotor symptoms
FemRing
higher dose, systemic effect May be used for vasomotor symptoms Rememeber your progestin in patients with uterus
Urogenital Symptoms
Local estrogen can improve atrophic vaginitis, irritative symptoms, coital discomfort No clear evidence to support use for presumed secondary incontinence
Pursue alternative diagnoses
Questions ?